SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-038855
Filing Date
2023-08-09
Accepted
2023-08-09 17:21:03
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc20057098_10q.htm   iXBRL 10-Q 1813300
2 EXHIBIT 10.1 brhc20057098_ex10-1.htm EX-10.1 23110
3 EXHIBIT 31.1 brhc20057098_ex31-1.htm EX-31.1 12209
4 EXHIBIT 31.2 brhc20057098_ex31-2.htm EX-31.2 12238
5 EXHIBIT 32.1 brhc20057098_ex32-1.htm EX-32.1 7222
11 image01.jpg GRAPHIC 43027
12 image02.jpg GRAPHIC 35672
  Complete submission text file 0001140361-23-038855.txt   9477778

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rckt-20230630.xsd EX-101.SCH 56744
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20230630_cal.xml EX-101.CAL 76425
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20230630_def.xml EX-101.DEF 301273
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20230630_lab.xml EX-101.LAB 827942
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20230630_pre.xml EX-101.PRE 467619
72 EXTRACTED XBRL INSTANCE DOCUMENT brhc20057098_10q_htm.xml XML 1792496
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 231156332
SIC: 2834 Pharmaceutical Preparations